Plasma interleukin-10 levels and adverse outcomes in acute coronary syndrome

American Journal of Medicine

Volumn 124, Issue 8, 2011, Pages 724-730

  Cavusoglu, Erdal ^a,b   Marmur, Jonathan D ^b   Hojjati, Mohammad R ^b   Chopra, Vineet ^a   Butala, Mitul ^b   Subnani, Rakesh ^b   Huda, Mohammad S ^b   Yanamadala, Sunitha ^c   Ruwende, Cyril ^c   Eng, Calvin ^a   Pinsky, David J ^c  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b SUNY Downstate Medical Center   (United States)

^c UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Acute coronary syndrome; Biomarker; Inflammation; Interleukin 11; Prognosis

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; C REACTIVE PROTEIN; INTERLEUKIN 10;

ACUTE CORONARY SYNDROME; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CARDIOVASCULAR RISK; DEATH; EVENT FREE SURVIVAL; FOLLOW UP; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGNOSIS; SENSITIVITY AND SPECIFICITY; SURVIVAL RATE; SURVIVAL TIME;

ACUTE CORONARY SYNDROME; AGED; ANGINA, UNSTABLE; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CONFOUNDING FACTORS (EPIDEMIOLOGY); HOSPITALS, VETERANS; HUMANS; INTERLEUKIN-10; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYOCARDIAL INFARCTION; NATRIURETIC PEPTIDE, BRAIN; NEW YORK CITY; PEPTIDE FRAGMENTS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; ROC CURVE; TIME FACTORS; TREATMENT OUTCOME;

EID: 79960781496     PISSN: 00029343     EISSN: 15557162     Source Type: Journal    
DOI: 10.1016/j.amjmed.2011.02.040     Document Type: Article

References (18)

1. Z. Mallat, S. Besnard, and M. Duriez Protective role of interleukin-10 in atherosclerosis Circ Res 85 1999 e17 e24
2. J.E. de Vries Immunosuppressive and anti-inflammatory properties of interleukin 10 Ann Med 27 1995 537 541
3. R. de Waal Malefyt, J. Abrams, B. Bennett, C.G. Figdor, and J.E. de Vries Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes J Exp Med 174 1991 1209 1220
4. L.J. Pinderski Oslund, and C.C. Hedrick Interleukin-10 blocks atherosclerotic events in vitro and in vivo Arterioscler Thromb Vasc Biol 19 1999 2847 2853 (Pubitemid 30029809)
5. D.A. Smith, S.D. Irving, J. Sheldon, D. Cole, and J.C. Kaski Serum levels of the antiinflammatory cytokine interleukin-10 are decreased in patients with unstable angina Circulation 104 2001 746 749 (Pubitemid 32762668)
6. C. Heeschen, S. Dimmeler, and C.W. Hamm Serum level of the antiinflammatory cytokine interleukin-10 is an important prognostic determinant in patients with acute coronary syndromes Circulation 107 2003 2109 2114 (Pubitemid 36532192)
7. A. Malarstig, P. Eriksson, A. Hamsten, B. Lindahl, L. Wallentin, and A. Siegbahn Raised interleukin-10 is an indicator of poor outcome and enhanced systemic inflammation in patients with acute coronary syndrome Heart 94 2008 724 729 (Pubitemid 351744689)
8. E. Cavusoglu, C. Ruwende, and V. Chopra Adiponectin is an independent predictor of all-cause mortality, cardiac mortality, and myocardial infarction in patients presenting with chest pain Eur Heart J 27 2006 2300 2309 (Pubitemid 44453573)
9. E. Cavusoglu, C. Ruwende, and C. Eng Usefulness of baseline plasma myeloperoxidase levels as an independent predictor of myocardial infarction at two years in patients presenting with acute coronary syndrome Am J Cardiol 99 2007 1364 1368 (Pubitemid 46686633)
10. D.F. Fiorentino, A. Zlotnik, T.R. Mosmann, M. Howard, and A. O'Garra IL-10 inhibits cytokine production by activated macrophages J Immunol 147 1991 3815 3822
11. E. Lindmark, T. Tenno, J. Chen, and A. Siegbahn IL-10 inhibits LPS-induced human monocyte tissue factor expression in whole blood Br J Haematol 102 1998 597 604 (Pubitemid 28346606)
12. B.M. Scirica, D.A. Morrow, and C.P. Cannon Clinical application of C-reactive protein across the spectrum of acute coronary syndromes Clin Chem 53 2007 1800 1807 (Pubitemid 47509673)
13. B.M. Scirica, C.P. Cannon, and M.S. Sabatine Concentrations of C-reactive protein and B-type natriuretic peptide 30 days after acute coronary syndromes independently predict hospitalization for heart failure and cardiovascular death Clin Chem 55 2009 265 273
14. E. Cavusoglu, C. Eng, V. Chopra, L.T. Clark, D.J. Pinsky, and J.D. Marmur Low plasma RANTES levels are an independent predictor of cardiac mortality in patients referred for coronary angiography Arterioscler Thromb Vasc Biol 27 2007 929 935 (Pubitemid 46606727)
15. R. Schnabel, C.M. Messow, and E. Lubos Association of adiponectin with adverse outcome in coronary artery disease patients: results from the AtheroGene study Eur Heart J 29 2008 649 657
16. V. Menon, L. Li, and X. Wang Adiponectin and mortality in patients with chronic kidney disease J Am Soc Nephrol 17 2006 2599 2606 (Pubitemid 44300977)
17. B. Dieplinger, M. Haltmayer, W. Poelz, and T. Mueller Value of adiponectin as predictor of 5-year all-cause mortality in patients with symptomatic peripheral arterial disease: results from the Linz Peripheral Arterial Disease (LIPAD) study Clin Chim Acta 408 2009 87 91
18. H. Teoh, M.H. Strauss, P.E. Szmitko, and S. Verma Adiponectin and myocardial infarction: a paradox or a paradigm? Eur Heart J 27 2006 2266 2268 (Pubitemid 44453566)